// App-Quantinova.ai

P567 : Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study

Researchers

Presenter

  • Honap, S

Principal Investigators

  • Sharma, E

  • Ray, S

  • Mawdsley, J

  • Anderson, S

  • Samaan, M

  • Pavlidis, P

  • Irving, P

Medical Centers

  • Guy’s and Saint Thomas’ Hospitals NHS Trust, Department of Gastroenterology, London, United Kingdom

  • King’s College London, School of Immunology and Microbial Sciences, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • Observational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved